Natriumchloride Aguettant (Sodium Chloride)

Natriumchloride Aguettant, an intravenous electrolyte solution, is used in clinical situations that require restoration of extracellular fluid volume and sodium balance.

• Fluid replacement: restores intravascular volume and maintains hemodynamic stability in patients with dehydration or blood loss.
• Electrolyte replenishment: corrects deficits of sodium and chloride during surgery, trauma, or intensive care management.
• Hyponatremia: raises serum sodium concentrations to safe levels in individuals with low sodium syndromes.
• Pre‑operative preparation: supplies isotonic saline to optimize intravascular volume before anesthesia and surgery.
• Post‑operative care: maintains fluid and electrolyte homeostasis during recovery after surgical procedures.

• Sodium chloride solution provides Na+ and Cl‑ ions that distribute into the extracellular compartment, increasing osmolarity and expanding plasma volume. The added sodium drives water retention via osmotic forces, while chloride helps maintain electrical neutrality, collectively restoring normal serum electrolyte concentrations and supporting vascular tone. It also contributes to acid‑base balance by supplying chloride, which can replace bicarbonate in renal exchange processes.

Intravenous sodium chloride may be associated with adverse reactions, ranging from mild infusion‑related events to serious systemic effects.

Common Side Effects

• Infusion site discomfort: mild pain, erythema, or irritation at the catheter insertion point.
• Hypernatremia: elevated serum sodium levels when administered in excess.
• Hyperchloremia: increased chloride concentration that may alter acid‑base balance.
• Fluid overload: signs of edema or weight gain in patients with limited cardiac reserve.

Serious or Rare Side Effects

• Pulmonary edema: accumulation of fluid in the lungs causing respiratory distress.
• Severe electrolyte imbalance: marked shifts leading to cardiac arrhythmias or seizures.
• Anaphylactic reaction: rare hypersensitivity presenting with hypotension, rash, and airway compromise.

When using Natriumchloride Aguettant, clinicians should observe several precautionary measures to ensure patient safety.

• Assess fluid status: evaluate volume overload risk before initiation.
• Monitor electrolytes: check serum Na+ and Cl‑ levels regularly.
• Renal function: adjust infusion in patients with impaired kidney function.
• Cardiac conditions: use cautiously in heart failure or hypertension.
• Compatibility: ensure solution is compatible with other IV drugs before mixing.
• Store at ambient temperature: keep in original container, protect from light and moisture.

Natriumchloride Aguettant can interact with other agents that affect fluid and electrolyte balance.

Major Interactions (Avoid)

• Hypertonic saline: concurrent use may cause severe hypernatremia.
• Potassium chloride: combined administration can lead to hyperchloremic metabolic acidosis.
• Loop diuretics: may exacerbate electrolyte disturbances if not monitored.

Moderate Interactions (Monitor Closely)

• ACE inhibitors: may increase risk of hyperkalemia when fluid shifts occur.
• Corticosteroids: can augment sodium retention, requiring electrolyte monitoring.
• Blood products: co‑administration may affect chloride balance.